Skip to product information
1 of 1

Elabscience

SKU:PKSH033410

Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag)

Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag)

Regular price $200.00 USD
Regular price Sale price $200.00 USD
Sale Sold out
Shipping calculated at checkout.
Size
Introducing the Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag), a cutting-edge product designed to revolutionize the field of immunology. This protein, derived from the recombinant human Interleukin-2 receptor gamma chain (IL2RG/CD132), encompasses amino acids 23 to 262, and is fused with a Fc tag for enhanced stability and functionality.

The Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag) offers a myriad of applications in various research areas, particularly in the study of immune responses and related disorders. With its precise amino acid sequence and the inclusion of the Fc tag, this protein exhibits exceptional binding affinity and stability, ensuring reliable and reproducible results.

This product is meticulously manufactured using state-of-the-art recombinant DNA technology, guaranteeing high purity and bioactivity. Its Fc tag not only facilitates purification processes but also enables versatile conjugation options for downstream applications, such as immunoassays, protein-protein interaction studies, and therapeutic antibody development.

The Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag) is supplied in lyophilized form, ensuring long-term stability and ease of storage. Prior to use, reconstitution with sterile water is required to restore its full functionality. The recommended concentration and usage guidelines are provided in the accompanying product manual, ensuring optimal experimental conditions.

In summary, the Recombinant Human IL2RG/CD132 Protein (aa 23-262, Fc Tag) represents a breakthrough in immunological research, offering researchers a reliable and versatile tool to unravel the complexities of immune responses. With its exceptional purity, stability, and bioactivity, this protein is poised to accelerate advancements in the field and contribute to the development of novel therapeutic strategies.
View full details